Thymosin Alpha-1

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide originally isolated from thymosin fraction 5, a bovine thymus gland extract. It represents the N-terminal acetylated fragment of prothymosin alpha, a highly acidic protein found in various tissues, with the highest concentration in the thymus.

The thymus gland is a primary site of T-cell maturation. In vitro and in vivo models suggest Tα1 is involved in T-cell development and maturation processes.

Regulatory Context

A synthetic version of this peptide, known as thymalfasin, has regulatory approval as a drug product in some countries for specific indications. That approval applies only to the drug product and not to this research material.

Thymosin Alpha-1 is described in the literature as an immunomodulating agent, with reported activity across various immune cell populations, cytokine networks, and pattern recognition receptor signaling pathways.

T-Lymphocyte Effects

In research models, Tα1 has been observed to influence the differentiation of thymocytes into mature T-cells and the development of Th1 cells. It has been reported to increase the expression of IL-2 receptors on T-cell surfaces and increase the production of cytokines such as IL-2 and IFN-γ (interferon-gamma), which is associated with T-cell cytotoxic function.

Natural Killer Cell Activation

In studies of natural killer (NK) cells, Tα1 has been associated with increased cytotoxic activity, IFN-γ production, and antibody-dependent cellular cytotoxicity (ADCC).

Dendritic Cell Maturation

Tα1 has been reported to promote the maturation of dendritic cells and increase the expression of MHC molecules and costimulatory molecules involved in T-cell activation, along with increased production of IL-12.

Toll-Like Receptor Signaling

Thymosin Alpha-1 has been shown in some models to interact with Toll-like receptors (TLRs), such as TLR2 and TLR9. At a molecular level, its activity has been linked to intracellular signaling cascades including the NF-κB and MAPK pathways.

Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

Laboratory Handling

Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

Research Limitations

Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.